Clinical Research Directory
Browse clinical research sites, groups, and studies.
Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia
Sponsor: Michael Boisen
Summary
HBOC-201 provides an oxygen treatment bridge and can be used to eliminate, delay, or reduce the need for red blood cell transfusions in anemic patients This is an expanded access IND protocol, and will provide treatment with HBOC-201 to severely anemic adults for whom blood is not an option
Official title: An Expanded IND Access Investigation of HBOC-201 Infusion in Patients With Severe Acute Anemia Who Are Unable to Receive Red Blood Cell Transfusion
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-07-20
Healthy Volunteers
Not specified
Conditions
Interventions
HBOC-201
Intravenous administration of a hemoglobin based oxygen carrier (HBOC) in patients with life-threatening anemia, for whom allogeneic blood transfusion is not an option.
Locations (1)
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States